PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 2025Egyptian Liver Journal0 citationsOpen Access

Exploring animal models and in vitro models for liver diseases: a review

View Full Paper
NBNarendra BhattAPAnil Kumar PrajapatiGSGaurang Shah

Key Points

  • The review finds that animal models are essential for replicating human liver pathology, but their relevance varies across diseases.
  • Key evidence indicates that advanced in vitro models, like 3D cultures, improve the understanding of liver microenvironments and drug responses.
  • This analysis highlights the need for combining animal and in vitro models to better grasp chronic liver disease mechanisms and therapy development.
  • Integrating these models emphasizes their potential to accelerate drug screening and identification of new therapeutic targets for chronic liver diseases.

Abstract

Abstract Chronic liver disease (CLD) remains a major global health concern, necessitating robust experimental models for advancing research and therapy development. This review highlights the crucial role of both animal and in vitro models in elucidating disease mechanisms and identifying therapeutic targets. Key findings highlight that while chemically and drug-induced animal models effectively replicate aspects of human liver pathology, their translational relevance varies depending on the disease context. In vitro models, particularly 3D cultures and microfluidic systems, are rapidly evolving to mimic the liver’s complex microenvironment better, improving drug screening and mechanistic studies. The review highlights that an integrative approach—combining suitable animal models and advanced in vitro models—offers the greatest potential for understanding CLD progression and accelerating the development of effective, targeted treatments. This comprehensive review covers animal and in vitro models of chronic liver diseases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bhatt et al. (2025) studied this question.

synapsesocial.com/papers/68d44f7b31b076d99fa56e7ahttps://doi.org/10.1186/s43066-025-00459-3
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques2024 · 24 citations
  2. 2Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases2006 · 147 citations
  3. 3Animal models in the study of hepatitis C virus-associated liver pathologies2011 · 27 citations
  4. 4Seabuckthorn berry polysaccharide protects against carbon tetrachloride-induced hepatotoxicity in mice via anti-oxidative and anti-inflammatory activities2017 · 81 citations
  5. 5Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review2019 · 227 citations